IAP antagonist GDC-0917 is more potent than Debio1143 in promoting cell death, c-IAP1 degradation and tumor growth inhibition

Bibliographic Details
Main Authors: Bruno Alicke, Eugene Varfolomeev, Shi Hui Kaylee Lee, Alexandra Frommlet, Savita Ubhayakar, John G. Quinn, Wayne J. Fairbrother, Robert Jones, Stephen E. Gould, Domagoj Vucic
Format: Article
Language:English
Published: Nature Publishing Group 2022-09-01
Series:Cell Death and Disease
Online Access:https://doi.org/10.1038/s41419-022-05283-w